{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:50:05Z","timestamp":1786373405301,"version":"build-2736575974"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.2215\/cjn.10321014","type":"journal-article","created":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T21:55:15Z","timestamp":1436910915000},"page":"1371-1379","source":"Crossref","is-referenced-by-count":118,"title":["Risk Prediction for Early CKD in Type 2 Diabetes"],"prefix":"10.2215","volume":"10","author":[{"given":"Daniela","family":"Dunkler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun Fu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Heinze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Clase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheldon","family":"Tobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koon K.","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hertzel","family":"Gerstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes F.E.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Oberbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20230601","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States.","volume":"298","author":"Coresh","year":"2007","journal-title":"JAMA"},{"key":"R2-12-20230601","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/ki.1997.260","article-title":"Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study.","volume":"51","author":"Hunsicker","year":"1997","journal-title":"Kidney Int"},{"key":"R3-12-20230601","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.2215\/CJN.04200511","article-title":"Predicting renal risk in the general population: Do we have the right formula?","volume":"6","author":"Taal","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R4-12-20230601","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1001\/jama.290.23.3101","article-title":"Screening for proteinuria in US adults: A cost-effectiveness analysis.","volume":"290","author":"Boulware","year":"2003","journal-title":"JAMA"},{"key":"R5-12-20230601","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0002-8703(91)90861-B","article-title":"Cardiovascular disease risk profiles.","volume":"121","author":"Anderson","year":"1991","journal-title":"Am Heart J"},{"key":"R6-12-20230601","doi-asserted-by":"crossref","first-page":"c5869","DOI":"10.1136\/bmj.c5869","article-title":"Population based screening for chronic kidney disease: Cost effectiveness study.","volume":"341","author":"Manns","year":"2010","journal-title":"BMJ"},{"key":"R7-12-20230601","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ahj.2004.03.020","article-title":"Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial\/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET\/TRANSCEND) trials.","volume":"148","author":"Teo","year":"2004","journal-title":"Am Heart J"},{"key":"R8-12-20230601","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events.","volume":"358","author":"Yusuf","year":"2008","journal-title":"N Engl J Med"},{"key":"R9-12-20230601","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(08)61236-2","article-title":"Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): A multicentre, randomised, double-blind, controlled trial.","volume":"372","author":"Mann","year":"2008","journal-title":"Lancet"},{"key":"R10-12-20230601","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0169-2607(02)00077-9","article-title":"Comparing the importance of prognostic factors in Cox and logistic regression using SAS.","volume":"71","author":"Heinze","year":"2003","journal-title":"Comput Methods Programs Biomed"},{"key":"R11-12-20230601","first-page":"26","article-title":"Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention).","volume":"155","author":"Gerstein","year":"2008","journal-title":"Am Heart J"},{"key":"R12-12-20230601","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1056\/NEJMoa1203859","article-title":"n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.","volume":"367","author":"Bosch","year":"2012","journal-title":"N Engl J Med"},{"key":"R13-12-20230601","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1203858","article-title":"Basal insulin and cardiovascular and other outcomes in dysglycemia.","volume":"367","author":"Gerstein","year":"2012","journal-title":"N Engl J Med"},{"key":"R14-12-20230601","doi-asserted-by":"crossref","first-page":"924","DOI":"10.2337\/diacare.29.04.06.dc06-1555","article-title":"Albumin-to-creatinine ratio in random urine samples might replace 24-h urine collections in screening for micro- and macroalbuminuria in pregnant woman with type 1 diabetes.","volume":"29","author":"Justesen","year":"2006","journal-title":"Diabetes Care"},{"key":"R15-12-20230601","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification.","volume":"139","author":"Levey","year":"2003","journal-title":"Ann Intern Med"},{"key":"R16-12-20230601","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1053\/j.ajkd.2012.04.025","article-title":"Prediction of kidney-related outcomes in patients with type 2 diabetes.","volume":"60","author":"Jardine","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"R17-12-20230601","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archinte.158.9.998","article-title":"Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.","volume":"158","author":"Ravid","year":"1998","journal-title":"Arch Intern Med"},{"key":"R18-12-20230601","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.2337\/db05-1620","article-title":"Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74.","volume":"55","author":"Retnakaran","year":"2006","journal-title":"Diabetes"},{"key":"R19-12-20230601","first-page":"1682","article-title":"Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus.","volume":"173","author":"Dunkler","year":"2013","journal-title":"JAMA Intern Med"},{"key":"R20-12-20230601","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1681\/ASN.2010091001","article-title":"Changes in albuminuria predict mortality and morbidity in patients with vascular disease.","volume":"22","author":"Schmieder","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R21-12-20230601","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jclinepi.2007.03.002","article-title":"Polytomous logistic regression analysis could be applied more often in diagnostic research.","volume":"61","author":"Biesheuvel","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"R22-12-20230601","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1055\/s-0038-1634008","article-title":"Building multivariable regression models with continuous covariates in clinical epidemiology--with an emphasis on fractional polynomials.","volume":"44","author":"Royston","year":"2005","journal-title":"Methods Inf Med"},{"key":"R24-12-20230601","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0895-4356(01)00341-9","article-title":"Internal validation of predictive models: Efficiency of some procedures for logistic regression analysis.","volume":"54","author":"Steyerberg","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"R25-12-20230601","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1002\/sim.4780122413","article-title":"The relative importance of prognostic factors in studies of survival.","volume":"12","author":"Schemper","year":"1993","journal-title":"Stat Med"},{"key":"R27-12-20230601","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.amjmed.2011.09.009","article-title":"A risk score for chronic kidney disease in the general population.","volume":"125","author":"O\u2019Seaghdha","year":"2012","journal-title":"Am J Med"},{"key":"R28-12-20230601","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1524-4733.2009.00668.x","article-title":"Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: A modeled analysis.","volume":"13","author":"Howard","year":"2010","journal-title":"Value Health"},{"key":"R29-12-20230601","doi-asserted-by":"crossref","first-page":"e1001344","DOI":"10.1371\/journal.pmed.1001344","article-title":"Risk models to predict chronic kidney disease and its progression: A systematic review.","volume":"9","author":"Echouffo-Tcheugui","year":"2012","journal-title":"PLoS Med"},{"key":"R30-12-20230601","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ki.2010.531","article-title":"Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts.","volume":"80","author":"Gansevoort","year":"2011","journal-title":"Kidney Int"},{"key":"R31-12-20230601","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2215\/CJN.01381005","article-title":"Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: The RENAAL study.","volume":"1","author":"Keane","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R32-12-20230601","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1053\/j.ajkd.2008.04.026","article-title":"Predicting the risk of dialysis and transplant among patients with CKD: A retrospective cohort study.","volume":"52","author":"Johnson","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"R33-12-20230601","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1471-2296-11-49","article-title":"Predicting the risk of chronic kidney disease in men and women in England and Wales: Prospective derivation and external validation of the QKidney Scores.","volume":"11","author":"Hippisley-Cox","year":"2010","journal-title":"BMC Fam Pract"},{"key":"R34-12-20230601","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/jama.2011.451","article-title":"A predictive model for progression of chronic kidney disease to kidney failure.","volume":"305","author":"Tangri","year":"2011","journal-title":"JAMA"},{"key":"R35-12-20230601","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.2215\/CJN.08590910","article-title":"Development and validation of a general population renal risk score.","volume":"6","author":"Halbesma","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R36-12-20230601","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1046\/j.1523-1755.2003.00923.x","article-title":"Predicting end-stage renal disease: Bayesian perspective of information transfer in the clinical decision-making process at the individual level.","volume":"63","author":"Dimitrov","year":"2003","journal-title":"Kidney Int"},{"key":"R37-12-20230601","doi-asserted-by":"crossref","first-page":"310","DOI":"10.7326\/0003-4819-154-5-201103010-00005","article-title":"Estimated glomerular filtration rate and albuminuria as predictors of outcomes in patients with high cardiovascular risk: A cohort study.","volume":"154","author":"Clase","year":"2011","journal-title":"Ann Intern Med"},{"key":"R38-12-20230601","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1523-1755.2003.00712.x","article-title":"Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64).","volume":"63","author":"Adler","year":"2003","journal-title":"Kidney Int"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201508000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:45:37Z","timestamp":1786369537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201508000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.10321014","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}